1 Arch Therapeutics Inc Receivables Turnover Ratio (ARTH), from the third quarter 2024 to the third quarter 2023 current and historic results, rankings and more - CSIMarket

Company Name, Ticker, Suppliers, else..

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

• Sales per Employee

• Income per Employee

• Inventory Turnover

• Asset Turnover

• Receivables Turnover

Dividend Comparisons

Arch Therapeutics Inc (ARTH)

Sector • Healthcare Industry • Medical Equipment & Supplies

Industry • Medical Equipment & Supplies

Sector • Healthcare

Arch Therapeutics Inc Accounts Receivables Turnover Ratio from the third quarter 2024 to the third quarter 2023

Quarterly Results, Trends, Rankings, Statistics

According to Arch Therapeutics Inc Balance Sheet, in the third quarter 2024, company has not reported any Accounts receivable.
See Arch Therapeutics Inc Balance Sheet

If we take a look into Healthcare sector 505 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2024 from 0 to 3317.

What is Receivable Turnover Ratio?
What is Arch Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ARTH Receivables Turnover Ratio	(Jun 30 2024) III. Quarter	(Mar 31 2024) II. Quarter	(Dec 31 2023) I. Quarter	(Sep 30 2023) IV. Quarter	(Jun 30 2023) III. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	132.55 %	91.34 %	632.58 %	2423.37 %	112.31 %
Receivable Turnover Ratio (TTM)	-	-	-	-	-
ARTH's Total Ranking	# 3317	# 0	# 0	# 3502	# 0
Accounts Receivable average collection period days	-	-	-	-	-
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-2.99 %	-30.53 %	16.07 %	197.27 %	-20.18 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 173
Healthcare Sector	# 506
Overall Market	# 3317

Receivable Turnover Ratio Statistics
High	Average	Low
9.09	3.86	0.04
(Dec 31 2022)		(Sep 30 2023)

ARTH Company Profile • Back to ARTH Efficiency Comparisons • Compare ARTH Receivables Turnover Ratio to its Competitors

Financial Statements
Arch Therapeutics Inc 's Accounts Receivable	$ 0 Millions	Visit ARTH's Balance sheet
Arch Therapeutics Inc 's Sales TTM	$ 0 Millions	Visit ARTH's Income Statement
Sources of ARTH's Revenues		Visit ARTH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ARTH's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ARTH's Growth Rates	ARTH's Roa	ARTH's Inventory Turnover Ratio	ARTH's Dividend Comparisons
ARTH's Profitability Ratios	ARTH's Roi	ARTH's Asset Turnover Ratio	ARTH's Dividend Growth
ARTH's Valuation Ratios	ARTH's Roe	ARTH's Financial Strength Ratios	ARTH's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Jun 30 2024

Receivable at quarter ending Jun 30 2024

Date modified: 2026-06-22T16:42:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.